QTTB (Q32 Bio Corp) Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik Q32 Bio Corp (QTTB)

The lack of commercial sales and pricing power is due to the current stage of clinical trials. Q32 Bio Inc. revenues will be based on the commercialization of targeted immunotherapy for inflammatory pathologies. The enterprise value-to-revenue ratio on the GURU.Markets terminal line chart reflects the asset's dynamics, where the value -571.64 captures the metric level. The issuer's prospects depend on research results and the market valuation of the sector.

q32bio.com - Multiplikator EV/Sales QTTB (periode 23.11.2025 - 20.11.2026)

QTTB (Q32 Bio Corp): rincian analitis lan laporan miturut indikator

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:Q32 Bio Inc QTTB
Produk asli Q32 Bio Inc

For Q32 Bio Inc., which develops treatments for autoimmune pathologies, the EV-to-revenue ratio reflects market expectations for the future commercialization of patents relative to current R&D expenditures. This indicator compares the total enterprise value with sales volume, excluding the impact of debt load, which allows for an assessment of the premium for potential operating leverage and the asset's fundamental attractiveness.

Analisis pesaing Q32 Bio Inc.

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Multiplikator EV/Sales CABA (cabalettabio.com)|Koefisien nilai perusahaan marang pendapatan VTYX (Ventyx Bio)|Theratechnologies, Inc - Multiplikator EV/Sales|AVTX (Avalo Therapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|eledon.com (ELDN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AGEN|CLYM (climbbio.com) - Multiplikator EV/Sales|Multiplikator EV/Sales zurabio.com|Rasio nilai perusahaan marang pendapatan aTyr (ATYR)|ADAG - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ImageneBio Inc IMA|Multiplikator EV/Sales Shattuck Labs, Inc. STTK|EQ - Rasio nilai perusahaan marang pendapatan|connectbiopharm.com (CNTB) - Nilai perusahaan marang pendapatan|IMUX (Immunic) - Nilai perusahaan marang pendapatan|Atara Biotherapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan InflaRx|Nilai perusahaan marang pendapatan x4pharma.com (XFOR)|Multiplikator EV/Sales ACET|Nilai perusahaan marang pendapatan Celularity Corp CELU|INmune Bio Inc - Nilai perusahaan marang pendapatan|BRNS (Barinthus Bio) - Nilai perusahaan marang volume dodolan|KZR - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Rasio nilai perusahaan marang pendapatan|ENLV - Rasio total nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD